United States v. Chirinos de Urena — Sixth Circuit affirmed the counterfeit-drug sentence

Case
United States v. Michael Basalyga; United States v. Reina Chirinos de Urena
Court
U.S. Court of Appeals for the Sixth Circuit
Judge
GRIFFIN; READLER; RITZ
Date Decided
October 19, 2026
Docket No.
25-5976
Topics
Sentencing Guidelines, Counterfeit Drugs, Immigration Consequences
Source
Read the full opinion

Background

Reina Chirinos de Urena participated for roughly three years in a conspiracy that manufactured and sold millions of counterfeit generic Xanax pills through the dark web and other illicit channels. She mixed chemicals in a storage unit, pressed the mixture into pills, and packaged large quantities for shipment. She pleaded guilty to conspiracy and substantive counterfeiting of drugs.

The district court calculated a Guidelines range of 57 to 71 months and sentenced Chirinos de Urena to 45 months in prison. On appeal, she challenged the version of the Guidelines used, the calculation of loss, a two-level enhancement for creating a conscious or reckless risk of death or serious bodily injury, and the district court’s treatment of the immigration consequences of her conviction.

The Court’s Holding

The Sixth Circuit affirmed. It held that Chirinos de Urena waived any objection to the district court’s use of the pre-2024 Guidelines because her plea agreement recommended the 2021 Guidelines, she framed her sentencing arguments under a pre-2024 version, and she did not object when the court followed that approach. The court also rejected her challenge to the loss calculation, concluding that its analysis of the same issue in the consolidated appeal and in a co-conspirator’s case controlled.

The court upheld the risk-of-harm enhancement. Even assuming the government had to establish that Chirinos de Urena actually knew of the danger, the nature, duration, and scope of her participation supplied sufficient circumstantial evidence that she understood and consciously disregarded the risks of producing millions of crudely manufactured, unregulated pills. The court also held that the district judge adequately considered her possible deportation and ineligibility for Bureau of Prisons programs. The judge had discretion to treat those effects as collateral consequences rather than grounds for a further downward variance.

Key Takeaways

  • A defendant who affirmatively proceeds under an earlier version of the Sentencing Guidelines may waive an appellate argument that a newer version should have applied.
  • Actual awareness of a serious bodily-injury risk may be established through circumstantial evidence, including a defendant’s sustained and hands-on role in an inherently dangerous counterfeit-drug operation.
  • A sentencing court may consider immigration-related consequences without treating deportation risk or reduced access to prison programming as grounds for a downward variance.

Why It Matters

The decision underscores that sentencing positions taken in the district court can foreclose later challenges to the governing Guidelines. It also confirms that direct evidence of a defendant’s awareness is unnecessary when the operation’s obvious dangers and the defendant’s extensive participation support the finding.

For lawful permanent residents, the opinion reinforces that immigration consequences and limits on prison programming may be raised at sentencing, but the district court retains broad discretion over the weight those consequences receive.

✉️ Get tomorrow’s cases before your first coffee
Daily Case Law is our free morning digest — the most substantive new decisions, filtered to your jurisdictions and topics, each linking back here for the full analysis.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top